Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Contingent Liabilities

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Contingent Liabilities ₹925 Cr₹1,019 Cr₹89 Cr₹48 Cr₹83 Cr

What is the latest Contingent Liabilities ratio of MANKIND PHARMA ?

The latest Contingent Liabilities ratio of MANKIND PHARMA is ₹925 Cr based on Mar2026 Consolidated results.
Year Contingent Liabilities
Mar2026₹925 Cr
Mar2025₹1,019 Cr
Mar2024₹89 Cr
Mar2023₹48 Cr
Mar2022₹83 Cr

How is Contingent Liabilities of MANKIND PHARMA Trending?

Years Contingent Liabilities % Change
Mar2026 ₹925 Cr
-9.29
Mar2025 ₹1,019 Cr
1,045.33
Mar2024 ₹89 Cr
85.77
Mar2023 ₹48 Cr
-41.97
Mar2022 ₹83 Cr -

Compare Contingent Liabilities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹102,785.4 Cr 8.1% -2.2% 1.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,662.0 Cr 2% -4.4% 3.7% Stock Analytics
DIVIS LABORATORIES ₹257,903.0 Cr 7.1% 2.5% 46.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,306.0 Cr 1.4% -5.7% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹112,699.0 Cr 3.6% 8% 4.2% Stock Analytics
CIPLA ₹111,489.0 Cr 2% -0.2% -14.3% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

8.1%

-2.2%

1.2%

SENSEX

1.8%

2.3%

-11.9%


You may also like the below Video Courses